# A Study to Learn More About Prevenar 20 Once it is Out in the Korean Market

> **NCT06760208** · — · RECRUITING · sponsor: **Pfizer** · enrollment: 660 (estimated)

## Conditions studied

- Pneumococcal Immunization
- Safety

## Interventions

- **BIOLOGICAL:** Pneumococcal 20-valent conjugate vaccine

## Key facts

- **NCT ID:** NCT06760208
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-13
- **Primary completion:** 2027-03-01
- **Final completion:** 2027-03-01
- **Target enrollment:** 660 (ESTIMATED)
- **Last updated:** 2026-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06760208

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06760208, "A Study to Learn More About Prevenar 20 Once it is Out in the Korean Market". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06760208. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*